{
  "id": 8596,
  "url": "https://doi.org/10.1186/s13024-019-0325-5",
  "title": "Neuroimaging Biomarkers for Alzheimer’s Disease",
  "summary": "Currently, over five million Americans suffer with Alzheimer's disease (AD). In the absence of a cure, this number could increase to 13.8 million by 2050. A critical goal of biomedical research is to establish indicators of AD during the preclinical stage (i.e. biomarkers) allowing for early diagnosis and intervention. Numerous advances have been made in developing biomarkers for AD using neuroimaging approaches. These approaches offer tremendous versatility in terms of targeting distinct age-re",
  "authors": "Freddie Márquez, Michael A. Yassa",
  "category": "research",
  "topics": "healthcare",
  "orgs": null,
  "regions": "us",
  "published_at": "2019-06-07T00:00:00.000Z",
  "fetched_at": "2026-07-14T16:33:39.875Z",
  "source_slug": "openalex",
  "source_name": "OpenAlex",
  "source_homepage": "https://openalex.org",
  "ethics_ai_record_url": "https://ethics.ai/record/8596",
  "original_url": "https://doi.org/10.1186/s13024-019-0325-5",
  "evidence_status": "source-only",
  "attribution": "via ethics.ai"
}